openPR Logo
Press release

Biomarker Technologies Market Size to hit $58.6 billion by 2026, Top Prominent Players: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc.

04-23-2020 11:12 AM CET | Health & Medicine

Press release from: Allied Market Research

Biomarker Technologies Market

Biomarker Technologies Market

The biomarker technologies market accounted for $21,594 million in 2018 is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026.

Biomarker technologies are techniques that are used to find out biomarkers. These biomarkers are characteristics, genes, or molecules which are used to measure the biological parameters of the body. These biological parameters help in identification of various diseases and can also be helpful in drug discovery. Different technologies, which are used for the identification of biomarkers include next generation sequencing, polymerase chain reactions, immunoassays, and others. These techniques are utilized in various field of science and are mostly used in identification of different disease such as cancers, autoimmune diseases, infectious diseases, and others. Moreover, the use of biomarkers has revolutionized patient treatment, which has become more personalized leading to better treatment outcomes.

Download Report Sample (320 Pages PDF with Insights) @ https://www.alliedmarketresearch.com/request-sample/5293

The key factors that drive the growth of the global biomarker technologies market are rise in prevalence of various diseases such as cancer, autoimmune diseases, and others. The other factors that contribute toward the growth of the market include surge in research related to drug discovery and increase in healthcare expenditure. However, high initial investments for the discovery of biomarker can hamper the market growth to a certain extent. Whereas, surge in awareness associated with the need of early detection of various diseases such as cancers and high growth potential in emerging economies are anticipated to provide lucrative opportunities in the market during the forecast period.

On the basis of technology, the immunoassay segment was a major revenue contributor in 2018 and is expected to maintain its dominant position throughout the analysis period due to surge in prevalence of various diseases across the globe. For instance, the rise in prevalence of cancer contributes to the growth of biomarker technologies market as biomarkers serve as tools in diagnosis of cancer. Moreover, other diseases such as diabetes type 1, is highly prevalent worldwide. This factor contributes toward the growth of the biomarker technologies market. In addition, infectious diseases such as AIDS, tuberculosis, and others are also diagnosed using biomarkers. Therefore, the factors above mentioned are responsible for the growth of this segment. On the other side, next generation sequencing is expected to be the fastest growing segment during the forecast period as this technique is highly advantageous due to its property of differentiating between closely related tumor cells to provide better understanding of the growth of cancer. Moreover, the rise in research related to cancer worldwide is another factor that boosts the growth of this market.

Inquire More About This Report Before Making Decision To Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/5293

According to product, the consumables segment accounted for the highest market share in 2018, and is anticipated to maintain this trend during the forecast period, as consumables form an important part of biomarker testing. Instrument segment is the fastest growing segment during the forecast period owing to the technological advancements.

In 2018, North America accounted for the major share of biomarker technologies market size and is expected to continue this trend owing to higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced biomarker testing instruments and high prevalence of disease such as cancer, infectious diseases, neurological disorders, autoimmune diseases, and others. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period.

The major companies profiled Are:

o Agilent Technologies, Inc.
o Bio-Rad Laboratories, Inc.
o F. Hoffmann-La Roche AG
o Illumina, Inc.
o LI-COR, Inc.
o Merck KGAA
o PerkinElmer Inc.
o QIAGEN
o Shimadzu Corporation
o Thermo Fisher Scientific, Inc.

Key Findings of the Biomarker Technologies Market:

o Consumables occupied two-third share of the market in 2018.
o The next generation sequencing segment is anticipated to grow with the highest CAGR throughout the forecast period.
o The drug discovery segment accounted for half share of the global biomarker technologies market in 2018.
o The cardiovascular disorders segment is anticipated to grow at the highest rate during the analysis period.

Access Full Report @ https://www.alliedmarketresearch.com/biomarker-technologies-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarker Technologies Market Size to hit $58.6 billion by 2026, Top Prominent Players: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc. here

News-ID: 2021930 • Views: 671

More Releases from Allied Market Research

Smart Beacon Market Expected to Reach $103.94 Billion By 2030 at 37.7% CAGR | Gr …
Rise in modern-day communication technologies, surge in investments in proximity marketing, and increase in adoption of smart devices are the factors that drive the global smart beacon market growth. As per the report published by Allied Market Research, the global smart beacon market generated $3.28 billion in 2020, and is estimated to reach $103.94 billion by 2030, witnessing a CAGR of 37.7% from 2021 to 2030. The report provides a
Fantasy Sports Market in Asia-Pacific & Canada is Expected to Reach $3,739.8 Mil …
According to a new report published by Allied Market Research, titled, “Asia-Pacific & Canada Fantasy Sports Market by Sports Type, Platform, and Demographic: Regional Opportunity Analysis and Industry Forecast, 2021–2027,” Asia-Pacific & Canada fantasy sports market size was valued at $2,021.9 million in 2019, and is projected to reach $3,739.8 million by 2027, growing at a CAGR of 10.7% from 2021 to 2027. Fantasy sport is played using internet where participants
Hammock Market Size Is Projected Reach $639.8 Million By 2030, Registering At A …
Surge in hiking and adventure tourism, rise in demand from residential segment, and expansion of hospitality industry drive the growth of the global hammock market. North America contributed to the highest share in terms of revenue in 2020. The outbreak of the COVID-19 pandemic has resulted in transition of consumers toward online sales channels to purchase campaigning gear products including hammocks. According to the report published by Allied Market Research, the
Cotton Personal-Care Product Market 2021: Top Factors That Are Leading The Deman …
A lead analyst at AMR highlighted the market across Europe region is expected to dominate in terms of revenues throughout the forecast period. Allied Market Research published a research report on the Cotton personal-care product market. The findings of the report states that the global market for Cotton personal-care product is expected to reach $19.15 billion by 2028, manifesting a CAGR of 4.6% from 2020 to 2028. The report provides valuable

All 5 Releases


More Releases for Biomarker

Global Biomarker Market Analysis by 2020-2025
Global Info Research offers a latest published report on Biomarker Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Biomarker Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/Global-Biomarker_p507728.html Market Overview The Biomarker
Global Metabolomics Biomarker Market Research and Forecast 2018-2023
Global metabolomics biomarker market size, share, market trends, research and analysis report by application (toxicological studies, drug testing, cancer, cardiovascular, neurological, inborn errors of metabolism) forecast 2018-2023 According to the OMR analysis, the global metabolomics biomarker market is growing at a significant rate during 2018-2023. Metabolomics are profiling of metabolites in biofluids, cells and tissues, which are routinely applied as a tool for biomarker discovery. Due to innovation and developments in
Key Findings of the Global Biomarker Market
A new business intelligence report released by HTF MI with title “Global Biomarker Market Size, Status and Forecast 2025” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. Request Sample Report @: https://www.htfmarketreport.com/sample-report/1222502-global-biomarker-market-1 If
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising